Evidence map›Paper›PMID 39887715›Full record

ArticleInternational journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics2025

The correlation between ANAs and pregnancy loss and their impact on IVF/ICSI-ET pregnancy outcomes in patients with recurrent pregnancy loss.

Manman Liu, Hebo Zhang, Shilian Xu, Rui Zhang, Mengfan Yuan, Bingnan Ren, Wenjuan Zhang, Zhaozhao Liu, Yichun Guan

Abstract read
In one paragraph

Article in International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. The correlation between ANAs and pregnancy loss and their impact on IVF/ICSI-ET pregnancy outcomes in patients with recurrent pregnancy loss.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Manman LiuDepartment of Reproductive Medicine, Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.ORCID https://orcid.org/0009-0000-0128-1148
Hebo ZhangDepartment of Reproductive Medicine, Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Shilian XuDepartment of Reproductive Medicine, Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Rui ZhangDepartment of Reproductive Medicine, Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Mengfan YuanDepartment of Reproductive Medicine, Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Bingnan RenDepartment of Reproductive Medicine, Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Wenjuan ZhangDepartment of Reproductive Medicine, Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Zhaozhao LiuDepartment of Reproductive Medicine, Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yichun GuanDepartment of Reproductive Medicine, Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Funding

Henan Province Medical Science and Technology Research Program (Joint Construction) LHGJ20190369National Key Research and Development Program of China 2021YFC2700602
6 · The paper itself

Abstract

objectiveTo explore the correlation between antinuclear antibodies (ANAs) and pregnancy loss (PL), and to observe its impact on the pregnancy outcomes of in vitro fertilization/intracytoplasmic sperm injection-embryo transfer (IVF/ICSI-ET) in recurrent PL (RPL) patients.

methodsIn this retrospective study, patients first seen at the hospital between January 2016 and December 2022 and who underwent two ANA tests within 4-6 weeks were included. After exclusion of confounding factors, patients were allocated to the non-pregnancy loss (non-PL), single-PL, or RPL group according to previous number of PLs, and the correlation between PL and ANAs was analyzed. The first embryo transfer (ET) after in vitro IVF/ICSI without immunological treatment was placed in the RPL group, and patients were classified into the ANA-negative or ANA-positive subgroup according to ANA titer. The effect of ANAs on pregnancy outcomes in the RPL patients after IVF/ICSI-ET was further analyze.

resultsThe results of multivariate unordered logistic regression showed that when the non-PL group was used as the reference, ANA positivity was an independent risk factor for RPL (P = 0.023) but not for single PL (P = 0.654). When the single-PL group was used as the reference, ANA positivity was an independent risk factor for RPL (P = 0.022). Multivariate logistic regression analysis revealed that the early PL rate of the ANA-positive subgroup was significantly higher than that of the ANA-negative subgroup (P = 0.009), and the total PL rate of the ANA-positive subgroup was significantly higher than that of the ANA-negative subgroup (P = 0.049).

conclusionThe results showed that ANA positivity may be related to RPL occurrence, but there was no significant correlation between ANA positivity and single PL. ANA positivity is associated with PL occurrence in RPL patients after transfer, and the correlation is reflected mainly in the first trimester.

Indexed as

Abortion, HabitualAntibodies, AntinuclearEmbryo TransferFertilization in VitroSperm Injections, IntracytoplasmicAdultFemaleHumansPregnancyPregnancy OutcomeRetrospective StudiesRisk FactorsAntibodies, Antinuclearantinuclear antibodyassisted reproductive technologypregnancy lossrecurrent pregnancy loss

Identifiers

PMID39887715
PMCPMC12177300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.